Filing Details
- Accession Number:
- 0001062993-23-016439
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-14 16:40:39
- Reporting Period:
- 2023-08-11
- Accepted Time:
- 2023-08-14 16:40:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 10795 | Becton Dickinson & Co | BDX | Surgical & Medical Instruments & Apparatus (3841) | 220760120 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1838891 | David Hickey | C/O Becton, Dickinson And Company Franklin Lakes NJ 07417 | Evp & President, Life Sciences | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-11 | 3,883 | $132.54 | 9,030 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-08-11 | 1,857 | $277.85 | 7,173 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2023-08-11 | 2,974 | $277.85 | 4,199 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2023-08-11 | 3,883 | $0.00 | 3,883 | $132.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-11-25 | 2024-11-25 | No | 4 | M | Direct |
Footnotes
- The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $277.41 to $280.00. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.
- Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.
- The stock appreciation rights vest in four annual installments beginning November 25, 2015.
Billionaire Hedge Funds
